Antiplatelet Therapy

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.2.1053
Version
20200909
PublisherACEP/AMA-PCPI StewardDate2020-09-09T01:00:32-04:00Purpose

(Clinical Focus: This value set contains concepts that represent antiplatlet therapies.),(Data Element Scope: This value set may use Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs concepts associated with component, form and strength); generic; prescribable; apixaban oral and injectable drugs: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, vorapaxar.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)

Expansion
<<>>>
CodeDisplaySystem
855820http://www.nlm.nih.gov/research/umls/rxnorm
206714http://www.nlm.nih.gov/research/umls/rxnorm
313406http://www.nlm.nih.gov/research/umls/rxnorm
597856http://www.nlm.nih.gov/research/umls/rxnorm
1656057http://www.nlm.nih.gov/research/umls/rxnorm
97http://www.nlm.nih.gov/research/umls/rxnorm
309953http://www.nlm.nih.gov/research/umls/rxnorm
1537045http://www.nlm.nih.gov/research/umls/rxnorm
1163137http://www.nlm.nih.gov/research/umls/rxnorm
315863http://www.nlm.nih.gov/research/umls/rxnorm
329449http://www.nlm.nih.gov/research/umls/rxnorm
1737472http://www.nlm.nih.gov/research/umls/rxnorm
1737466http://www.nlm.nih.gov/research/umls/rxnorm
1666331http://www.nlm.nih.gov/research/umls/rxnorm
236612http://www.nlm.nih.gov/research/umls/rxnorm
1165746http://www.nlm.nih.gov/research/umls/rxnorm
253202http://www.nlm.nih.gov/research/umls/rxnorm
108911http://www.nlm.nih.gov/research/umls/rxnorm
374583http://www.nlm.nih.gov/research/umls/rxnorm
213169http://www.nlm.nih.gov/research/umls/rxnorm